Jyothy Labs Ltd
Jyothy Labs Limited was founded in 1983 by Mr. M. P. Ramachandran in Thrissur, Kerala. JLL is renowned brand in the domestic FMCG industry.It has a diversified product portfolio spanning four major categories of fabric care, dishwashing, household insecticides (HI) and personal care and an established market position in the post-wash (under Ujala brand) and the dishwashing segments (under Pril and Exo brands). [1]
Strengths
- +Company is almost debt free.
- +Company has a good return on equity (ROE) track record: 3 Years ROE 28.1%
- +Company has been maintaining a healthy dividend payout of 36.0%
Weaknesses
- −The company has delivered a poor sales growth of 9.33% over past five years.
- −Working capital days have increased from 51.8 days to 77.7 days
Shareholding Pattern
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.89% | 62.89% | 62.89% | 62.88%▼0.0 | 62.88% | 62.88% | 62.89%▲0.0 | 62.89% |
| FIIs | 15.1% | 15.1% | 14.35%▼0.8 | 13.13%▼1.2 | 12.66%▼0.5 | 12.11%▼0.6 | 12.77%▲0.7 | 12.35%▼0.4 |
| DIIs | 14.35% | 15.26%▲0.9 | 15.25%▼0.0 | 16.25%▲1.0 | 15.98%▼0.3 | 16.08%▲0.1 | 15.14%▼0.9 | 14.62%▼0.5 |
| Public | 7.66% | 6.75%▼0.9 | 7.5%▲0.8 | 7.72%▲0.2 | 8.48%▲0.8 | 8.91%▲0.4 | 9.19%▲0.3 | 10.13%▲0.9 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 677 | 659 | 741 | 733 | 704 | 666 | 751 | 736 | 740 | 717 |
| Expenses | 558 | 551 | 608 | 595 | 588 | 554 | 627 | 618 | 629 | 621 |
| Operating Profit | 119 | 108 | 134 | 138 | 116 | 112 | 124 | 118 | 111 | 97 |
| OPM % | 18% | 16% | 18% | 19% | 16% | 17% | 17% | 16% | 15% | 13% |
| Net Profit | 91 | 78 | 102 | 105 | 87 | 77 | 97 | 88 | 81 | 68 |
| EPS ₹ | 2.48 | 2.13 | 2.77 | 2.86 | 2.38 | 2.1 | 2.64 | 2.39 | 2.21 | 1.84 |
AI Insights
Mar 2026 revenue at ₹2,944Cr, up 3.5% YoY. OPM at 15%.
Borrowings at ₹52Cr. Debt-to-equity ratio: 0.03x. Healthy balance sheet.
CWIP at ₹10Cr (2% of fixed assets). Moderate ongoing capital expenditure.
DIIs: 14.62% (-0.74pp change). FIIs: 12.35% (-1.62pp change). Promoters hold 62.89%.
ROCE improving from 11% (Mar 2015) to 30% (Mar 2026). Working capital days: 78.
PE 23.7x with 29.6% ROCE. Price is 397% above book value of ₹43.3. Dividend yield: 1.65%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 13 May - Jyothy Labs schedules one-on-one investor meet with Alf Accurate Advisors on May 15, 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 13 May - Jyothy Labs scheduled a one-on-one investor meet with Nippon India Mutual Fund on June 2, 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 May
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 May - Jyothy Labs schedules one-on-one investor meeting with SBI Mutual Fund on May 13, 2026.
- Board Meeting Outcome for Outcome Of Board Meeting Without Intimation 9 May - Henkel will not renew Pril license beyond May 31, 2026; financial impact under evaluation.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse